Publications by authors named "Rima A Mohammad"

Claim this Profile
A
An international, multicenter post hoc analysis comparing in-person and virtual medication management strategies in post-ICU recovery clinics.
Aeryana N Beaudrie-Nunn, Janelle O Poyant, Christine M Groth, Stephen H Rappaport, Rachel M Kruer, Rima A Mohammad

Am J Health Syst Pharm· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Inpatient Pharmacist-Led Medication Reconciliations on Medication-Related Interventions in Intensive Care Unit Recovery Centers.
Sarah K Singer, Kevin D Betthauser, Alexandra E Barber, Rebecca Bookstaver Korona, Deepali Dixit, Rima A Mohammad

Hosp Pharm· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An International, Multicenter Evaluation of Comprehensive Medication Management by Pharmacists in ICU Recovery Centers.
Joanna L Stollings, Janelle O Poyant, Christine M Groth, Stephen H Rappaport, Rachel M Kruer, Rima A Mohammad

J Intensive Care Med· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of Patient Safety Threats in a Post-Intensive Care Clinic.
Kevin J Karlic, Thomas S Valley, Leigh M Cagino, Hallie C Prescott, Theodore J Iwashyna, Rima A Mohammad

Am J Med Qual· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medication Changes and Diagnosis of New Chronic Illnesses in COVID-19 Intensive Care Unit Survivors.
Rima A Mohammad, Cynthia T Nguyen, Patrick G Costello, Janelle O Poyant, Siu Yan Amy Yeung

Ann Pharmacother· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changing patterns of the prevalence of burnout and secondary traumatic stress in health-system pharmacists throughout the COVID-19 pandemic.
Rima A Mohammad, Adam M Jones, John S Clark

J Am Coll Clin Pharm· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of the COVID-19 pandemic on medical conditions and medication adherence in people with chronic diseases.
Huda Ismail, Vincent D Marshall, Minal Patel, Madiha Tariq, Rima A Mohammad

J Am Pharm Assoc (2003)· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Electronic Decision Support Intervention Reduces Readmissions for Patients With Cirrhosis.
Jeremy Louissaint, Katie Grzyb, Linda Bashaw, Rima A Mohammad, Neehar D Parikh

Am J Gastroenterol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of a specialty hepatitis C virus telephone pharmacy service.
Ashley A Sabourin, Kaleigh K Fisher-Grant, Adam R Saulles, Rima A Mohammad

Am J Health Syst Pharm· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Burnout and secondary traumatic stress in health-system pharmacists during the COVID-19 pandemic.
Adam M Jones, John S Clark, Rima A Mohammad

Am J Health Syst Pharm· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Impact of Multiple Renal Estimates on Pharmacist Dosing Recommendations: A Randomized Trial.
Sean M McConachie, Claudia M Hanni, Joshua N Raub, Rima A Mohammad, Sheila M Wilhelm

Ann Pharmacother· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacists' Perceptions on Their Role, Activities, Facilitators, and Barriers to Practicing in a Post-Intensive Care Recovery Clinic.
Antoinette B Coe, Rebecca E Bookstaver, Andrew C Fritschle, Michael T Kenes, Pamela MacTavish, Rima A Mohammad

Hosp Pharm· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What Is Post-Intensive Care Syndrome (PICS)?
Samuel Kosinski, Rima A Mohammad, Mari Pitcher, Evan Haezebrouck, Antoinette B Coe

Am J Respir Crit Care Med· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Residents as preceptors and educators: What we can learn from a national survey to improve our residency programs.
Bethany A DiPaula, Rima A Mohammad, Phil Ayers, Vicki Basalyga, Aaron Burton

Curr Pharm Teach Learn· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The changing landscape of adverse drug events associated with chronic hepatitis C virus therapy.
Michael A Smith, Bryan L Love, Rima A Mohammad

Expert Opin Drug Saf· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic Advances in HCV Genotype 1 Infection: Insights from the Society of Infectious Diseases Pharmacists.
Paulina Deming, Michelle T Martin, Juliana Chan, Thomas J Dilworth, Rania El-Lababidi, Rima A Mohammad

Pharmacotherapy· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Daclatasvir: A NS5A Replication Complex Inhibitor for Hepatitis C Infection.
Michael A Smith, Randolph E Regal, Rima A Mohammad

Ann Pharmacother· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of an iPad to Provide Warfarin Video Education to Hospitalized Patients.
Jenny Jane Kim, Rima A Mohammad, Kim C Coley, Amy C Donihi

J Patient Saf· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Ledipasvir-sofosbuvir for hepatitis C genotype 4 infection.
Michael A Smith, Rima A Mohammad

Lancet Infect Dis· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Ledipasvir-sofosbuvir: interferon-/ribavirin-free regimen for chronic hepatitis C virus infection.
Michael A Smith, Juliana Chan, Rima A Mohammad

Ann Pharmacother· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vedolizumab: an α4β7 integrin inhibitor for inflammatory bowel diseases.
Michael A Smith, Rima A Mohammad

Ann Pharmacother· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Provision of clinical pharmacist services for individuals with chronic hepatitis C viral infection: Joint Opinion of the GI/Liver/Nutrition and Infectious Diseases Practice and Research Networks of the American College of Clinical Pharmacy.
Rima A Mohammad, Marilyn N Bulloch, Juliana Chan, Paulina Deming, Bryan Love

Pharmacotherapy· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence and Management of Rash in Telaprevir-Treated Patients.
Michael A Smith, Heather J Johnson, Kapil B Chopra, Michael A Dunn, Ashley M Ulrich, Rima A Mohammad

Ann Pharmacother· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of virtual patients in an advanced therapeutics pharmacy course to promote active, patient-centered learning.
Michael A Smith, Rima A Mohammad, Neal Benedict

Am J Pharm Educ· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Process indicators of quality clinical pharmacy services during transitions of care.

Pharmacotherapy· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis